GRAIL, Inc. Common Stock GRAL
$136.57
+2.97%
at last close
Market Cap$5.92 billion
P/E Ratio—
Div Yield—
Volume923.0K
52-Week Range
$30.82$140.88
Analyst Ratings
- Consensus
- Moderate Buy — 5 Buy · 5 Hold · 0 Sell (10 analysts)
- Avg. Price Target
- $87.70 (-35.8% downside)
Key Stats
- Today's Range
- $131.20 – $140.88
- 50-Day Range
- $60.76 – $140.88
- 52-Week Range
- $30.82 – $140.88
- Volume
- 923K shs
- Average Volume
- 1.14 million shs
- Market Cap
- $5.92 billion
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 2.33
- Price / Sales
- 35.85
Short Interest
- Short Interest
- 5.12%
- Days to Cover
- 1.00
Financials (TTM)
- Revenue
- $165.26 million
- Net Income
- $-391,587,000
- Net Margin
- -236.95%
- Return on Equity
- -15.40%
- Debt-to-Equity
- —
About GRAIL, Inc. Common Stock
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
Related Stocks
Compare head-to-head: GRAL vs NTRA·GRAL vs DGX·GRAL vs CAI·GRAL vs BLLN
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.